FDA Inspection
LifeShare Blood CentersLifeShare Blood Centers – FDA Inspection, Apr 5, 2013
Record Details
This FDA Inspection record concerns LifeShare Blood Centers, with an inspection on April 5, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- LifeShare Blood Centers
- Inspection Date
- April 5, 2013
- Product Type
- Biologics
View Company Profile
ID · a3258b25-f0b2-4a6b-8a00-42055fd19815
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 826041
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeShare Blood Centers
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 24, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 3, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 17, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Centers
- FDA Inspection 1254262 - 2024-11-04
- FDA Inspection 1098161 - 2019-06-24
- FDA Inspection 995056 - 2016-11-03
- FDA Inspection 900426 - 2014-10-17
- FDA Inspection 730854 - 2011-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.